Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine effects on QTc and QT dispersion in subclinical hypothyroidism
IRCT20210331050794N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: QT correction and QT dispersion. Started May 2021; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on IRCT20210331050794N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210331050794N1.